Showing 1,401 - 1,420 results of 11,505 for search '"The Progressives"', query time: 0.07s Refine Results
  1. 1401
  2. 1402
  3. 1403
  4. 1404

    Intervening Non-Small-Cell Lung Cancer Progression by Cell Membrane Coated Platycodin D via Regulating Hsa-miR-1246/FUT9/GSK3β Pathway by Zheng S, Xie Z, Zhou Z, Wang S, Xin Y, Lin J, Cheng K, Lu T, Qi R, Guo Y

    Published 2025-02-01
    “…Collectively, this study revealed the potential utility of PD in the treatment of NSCLC progression.Keywords: non-small cell lung cancer, platycodin D, anti-cancer phytomedicine, hsa-miR-1246, FUT9, cancer cell membrane…”
    Get full text
    Article
  5. 1405
  6. 1406

    Long non-coding RNA NEAT1 promotes ovarian granulosa cell proliferation and cell cycle progression via the miR-29a-3p/IGF1 axis by Lina He, Jie Lin, Zhengwen Qin, Qing Xu, Li Hao, Yanhong Fu, Xu Ran, Wei Chen

    Published 2025-01-01
    “…Results NEAT1 promoted granulosa cell proliferation and cell cycle progression by indirectly upregulated IGF1 expression through acting as a molecular sponge for miR-29a-3p. …”
    Get full text
    Article
  7. 1407
  8. 1408
  9. 1409
  10. 1410
  11. 1411
  12. 1412
  13. 1413

    Lerociclib plus fulvestrant in patients with HR+/HER2− locally advanced or metastatic breast cancer who have progressed on prior endocrine therapy: LEONARDA-1 a phase III randomized trial by Binghe Xu, Qingyuan Zhang, Yang Luo, Zhongsheng Tong, Tao Sun, Changping Shan, Xinlan Liu, Yumin Yao, Bing Zhao, Shusen Wang, Xiaohua Zeng, Changlu Hu, Xi Yan, Xiaojia Wang, Hongyan Jia, Zhendong Chen, Fuming Qiu, Xinhong Wu, Deyong Zhang, Tong Li

    Published 2025-01-01
    “…Progression-free survival (PFS) assessed by investigators was significantly improved in lerociclib arm versus placebo arm (11.07 vs 5.49 months; hazard ratio, 0.451, 95% CI: 0.311-0.656, P = 0.000016), meeting the pre-specified primary endpoint. …”
    Get full text
    Article
  14. 1414
  15. 1415
  16. 1416
  17. 1417
  18. 1418
  19. 1419
  20. 1420